Mpox Vaccine | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
June 09, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JUNE 09, 2025

Mpox Vaccine

The hands of a patient with skin rashes caused by the mpox virus are pictured at the treatment center of Vijana Hospital in Kinshasa, Democratic Republic of Congo August 30, 2024. Photo: REUTERS/Justin Makangara/File Photo
Health

WHO approves Bavarian Nordic's mpox vaccine for adolescents

The WHO said in a statement that it gave the Jynneos vaccine prequalification for adolescents on Oct. 8

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. Photo: REUTERS/Dado Ruvic/Illustration/File Photo
Health

Mpox vaccines to arrive in DR Congo in next few days: WHO

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. Photo: REUTERS/Dado Ruvic/Illustration/File Photo
Health

Nigeria to start mpox vaccination on October 8

A laboratory nurse takes a sample from a child declared a suspected case of Mpox at the treatment centre in Munigi, Democratic Republic of the Congo July 19, 2024. Photo: REUTERS/Arlette Bashizi/File Photo
Health

UNICEF issues emergency tender to secure mpox vaccines

An undated colorized transmission electron micrograph of mpox virus particles (pink) found within an infected cell (yellow), cultured in the laboratory, captured at the National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) in Fort Detrick, Maryland. Photo: NIAID/Handout via REUTERS
Africa

New mpox strain is changing fast; African scientists are ‘working blindly’ to respond

Internally displaced women listen to Nathalie Kipenzi, a hygiene promoter, during an awareness campaign for Mpox, an infectious disease caused by the monkeypox virus that causes a painful rash, enlarged lymph nodes and fever, at the Muja camp for the internally displaced in Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 19, 2024. Photo: REUTERS/Arlette Bashizi
Health

Why mpox vaccines are only just arriving in Africa after two years

A person holds doses of Bavarian Nordic's Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination centre in Paris, France July 27, 2022. Photo: Alain Jocard/Pool via REUTERS/File Photo
Health

WHO says partners can start talks to buy mpox vaccines before its approval

A laboratory nurse takes a sample from a child declared a suspected case of Mpox at the treatment centre in Munigi, Democratic Republic of the Congo July 19, 2024. Photo: REUTERS/Arlette Bashizi/File Photo
Health

Congo hopes to receive first mpox vaccines by next week

Dial 16263 or 10655 if mpox symptoms appear: Health directorate
Health

Dial 16263 or 10655 if mpox symptoms appear: Health directorate

Dr Pascaline Kahindo, checks the treatment progress on the feet of patient Ajuamungu Ntuyehe, undergoing the treatment of Mpox - an infectious disease caused by the monkeypox virus that sparks off a painful rash, enlarged lymph nodes and fever; at the treatment centre in Munigi, following Mpox cases in Nyiragongo territory near Goma, North Kivu province, Democratic Republic of the Congo July 19, 2024. Photo: REUTERS/Arlette Bashizi/File Photo
Europe

German infection expert: mpox vaccine's best use is in Africa right now

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net